Conclusion Reduced quality of life is a significant concern in the early period following allo-HSCT, especially among patients experiencing active GVHD
If you take anticoagulants like warfarin, discuss ginger supplementation with your healthcare provider before starting
S7, BV2 and HT22 cells treated with LAbs@Lip@Rapa and Lip@BMn/Rapa, respectively, showed significantly weaker red fluorescence compared with the H 2 O 2 -only-treated group, indicating elevated O levels inside the cells
The SURPASS-CVOT (Cardiovascular Outcomes Trial) is an ongoing dedicated study designed to assess cardiovascular outcomes in patients with type 2 diabetes at increased cardiovascular risk
Patients on blood thinners or with clotting disorders bruise more easily
If you have a mild deficiency or are using B12 injections for preventive purposes, you may require lower doses or less frequent administration